Introduction A major patent battle [1] has erupted in India between pharmaceutical giants Novo Nordisk and Dr. Reddy’s Laboratories over the popular weight loss and diabetes drug semaglutide. Novo Nordisk sued Dr. Reddy’s for manufacturing and exporting its patented drug without consent. This case is significant for the Indian pharmaceutical industry, as its outcome will […]